9341 Stock Overview
Engages in the medical platform and smart clinic businesses in Japan.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 6/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 9341 from our risk checks.
GENOVA, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,415.00 |
52 Week High | JP¥1,755.00 |
52 Week Low | JP¥1,070.00 |
Beta | 0 |
11 Month Change | -12.71% |
3 Month Change | 5.20% |
1 Year Change | -12.33% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -18.54% |
Recent News & Updates
Investors Give GENOVA, Inc. (TSE:9341) Shares A 29% Hiding
Aug 05These 4 Measures Indicate That GENOVA (TSE:9341) Is Using Debt Safely
Aug 03Shareholder Returns
9341 | JP Healthcare Services | JP Market | |
---|---|---|---|
7D | 7.6% | 6.6% | 7.5% |
1Y | -12.3% | -44.3% | 17.4% |
Return vs Industry: 9341 exceeded the JP Healthcare Services industry which returned -44.3% over the past year.
Return vs Market: 9341 underperformed the JP Market which returned 17.4% over the past year.
Price Volatility
9341 volatility | |
---|---|
9341 Average Weekly Movement | 7.9% |
Healthcare Services Industry Average Movement | 7.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in JP Market | 10.1% |
10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 9341 has not had significant price volatility in the past 3 months.
Volatility Over Time: 9341's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 352 | n/a | www.genova.co.jp |
GENOVA, Inc. engages in the medical platform and smart clinic businesses in Japan. It offers Medical Doc, a platform that distributes articles for medical institutions, patient experience articles, treatment videos, and medical-related articles. It also provides Smart Clinic, an online medical treatment and consultation service, which offers medical treatment at home or work for users without going to a hospital.
GENOVA, Inc. Fundamentals Summary
9341 fundamental statistics | |
---|---|
Market cap | JP¥25.18b |
Earnings (TTM) | JP¥1.82b |
Revenue (TTM) | JP¥9.32b |
13.8x
P/E Ratio2.7x
P/S RatioIs 9341 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9341 income statement (TTM) | |
---|---|
Revenue | JP¥9.32b |
Cost of Revenue | JP¥2.34b |
Gross Profit | JP¥6.98b |
Other Expenses | JP¥5.16b |
Earnings | JP¥1.82b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 102.38 |
Gross Margin | 74.92% |
Net Profit Margin | 19.56% |
Debt/Equity Ratio | 0.9% |
How did 9341 perform over the long term?
See historical performance and comparison